CDC42 and rheumatoid arthritis: (b) CDC42 suppressed immune response through multiple mechanisms (such as maintenance of T cell identity and regulation of T cell activation etc.)as discussed earlier, which thereby led to reduced inflammation and disease activity in RA patients [11–13].